Categories AlphaGraphs, Earnings, Technology

Earnings: AT&T narrowly misses top line in Q4

The world’s largest telecommunications company, AT&T (NYSE:T), Wednesday reported 15.2% jump in fourth-quarter revenue to $48 billion, partly helped by the Time Warner acquisition. Earnings for the quarter rose to 86 cents per share from 78 cents per share a year ago.

Analysts had projected earnings of 85 cents per share on a top line of $48.42 billion.

AT&T fourth quarter 2018 earnings infographic

The slight top-line miss sent AT&T shares down 2.2% during pre-market trading. The stock has seen an 18% decline in the past 52 weeks, as investors remained concerned over a continuous drop in linear TV subscribers.

Total wireless net adds were 3.8 million, with 2.8 million coming from the US, driven by smartphones and connected devices.

The company, which has been trying to establish itself as a telecom-entertainment firm through a slew of acquisitions, said it expects adjusted EPS growth in low single digits in 2019. Free cash flow is projected to be in the $26 billion range.

CEO Randall Stephenson said, “Our top priority for 2018 and 2019 is reducing our debt and I couldn’t be more pleased with how we closed the year. In 2018, we generated record free cash flow while investing at near-record levels.”

At the end of the fourth quarter, free cash flow rose 78% to $7.9 billion.

EBITDA in the Communications segment increased 6.7% in Q4, though in the Entertainment Group, it fell 9%.

On Tuesday, rival Verizon (VZ) reported fourth-quarter revenues that missed street projection, sending its shares down 3%. Sprint (S) is scheduled to report quarterly results on Thursday, January 31.

 

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text 

Most Popular

Cost reduction has become a priority for FedEx (FDX) after a challenging quarter

Shares of FedEx Corporation (NYSE: FDX) were up 1% on Tuesday. The stock has dropped 44% year-to-date and 34% over the past 12 months. The company delivered mixed results for

Prime Medicine is the next big biotech to pursue IPO. Here’s all you need to know

After a soft start to the year, the IPO market has witnessed muted activity so far though a few big companies entered the stock market. On the heels of AIG

Stock Watch: Is Darden Restaurants a good buy after earnings?

After a prolonged slowdown, the restaurant industry is returning to normal patterns but macroeconomic uncertainties and high inflation are currently playing spoilsport for it. While the pandemic-related slump forced many

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top